{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:43:51Z","timestamp":1786113831391,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaccas.2026.108889","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:52:32Z","timestamp":1781815952000},"page":"108889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fulminant Eosinophilic Myocarditis After Sequential Biologic Therapy in Ulcerative Colitis"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3529-5486","authenticated-orcid":false,"given":"Jinyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-0904","authenticated-orcid":false,"given":"Darae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Noeul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Oh","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaccas.2026.108889_bib1","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.14309\/ajg.0000000000002701","article-title":"Long-term risk of myocarditis in patients with inflammatory bowel disease: a nationwide cohort study in Sweden","volume":"119","author":"Sun","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jaccas.2026.108889_bib2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/ajg.2017.402","article-title":"Peripheral eosinophilia in patients with inflammatory bowel disease defines an aggressive disease phenotype","volume":"112","author":"Click","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jaccas.2026.108889_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7861\/clinmed.2020-0271","article-title":"Lessons of the month 2: chronic eosinophilic pneumonia (CEP): a rare manifestation of infliximab therapy","volume":"20","author":"Nadeem","year":"2020","journal-title":"Clin Med (Lond)"},{"issue":"11","key":"10.1016\/j.jaccas.2026.108889_bib4","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000905","article-title":"Vedolizumab-associated hypereosinophilia and hepatotoxicity","volume":"9","author":"De Marco","year":"2022","journal-title":"ACG Case Rep J"},{"issue":"9","key":"10.1016\/j.jaccas.2026.108889_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","article-title":"Paradoxical inflammation induced by anti-TNF agents in patients with IBD","volume":"9","author":"Cleynen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.jaccas.2026.108889_bib6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMra2114478","article-title":"Myocarditis","volume":"387","author":"Basso","year":"2022","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jaccas.2026.108889_bib7","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jaccas.2026.108889_bib8","article-title":"Interleukin-5 antagonist monoclonal antibody therapy improves symptoms and reduces steroid dependence in eosinophilic myocarditis patients","volume":"29","author":"Trovato","year":"2024","journal-title":"JACC Case Rep"},{"issue":"19","key":"10.1016\/j.jaccas.2026.108889_bib9","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3390\/jcm14196829","article-title":"Eosinophilic myocarditis treated with IL-5 blockade: an integrated case report and literature review","volume":"14","author":"Takahashi","year":"2025","journal-title":"J Clin Med"},{"issue":"19","key":"10.1016\/j.jaccas.2026.108889_bib10","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926020486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926020486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T19:58:43Z","timestamp":1785959923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926020486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666084926020486"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.108889","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fulminant Eosinophilic Myocarditis After Sequential Biologic Therapy in Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.108889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"108889"}}